Ah. Groll et al., INVASIVE PULMONARY ASPERGILLOSIS IN A CRITICALLY ILL NEONATE - CASE-REPORT AND REVIEW OF INVASIVE ASPERGILLOSIS DURING THE FIRST 3 MONTHS OF LIFE, Clinical infectious diseases, 27(3), 1998, pp. 437-452
We report a fatal case of invasive pulmonary aspergillosis in a severe
ly ill neonate and review 43 additional cases of invasive aspergillosi
s reported from 1955 through 1996 that occurred during the first 3 mon
ths of life. Eleven of the 44 patients had primary cutaneous aspergill
osis, 10 had invasive pulmonary aspergillosis, and 14 had disseminated
disease. Most infections were nosocomial in origin. Prematurity (43%)
; proven chronic granulomatous disease (14%); and a complex of diarrhe
a, dehydration, malnutrition, and invasive bacterial infections (23%)
accounted for the majority of underlying conditions. At least 41% of t
he patients had received corticosteroid therapy before diagnosis, but
only one patient had been neutropenic. Among patients who received med
ical and/or surgical treatment, outcome was relatively favorable, with
an overall survival rate of 73%. Invasive aspergillosis may occur in
neonates and young infants and warrants consideration under certain ci
rcumstances. Current therapeutic approaches consist of high-dose ampho
tericin B and appropriate surgical interventions.